BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 1402141)

  • 1. Comparative study of thermoradiosensitization by misonidazole and metronidazole in vivo: antitumour effect and pharmacokinetics.
    Wong KH; Maezawa H; Urano M
    Int J Hyperthermia; 1992; 8(5):645-58. PubMed ID: 1402141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The advantageous use of hypoxic tumour cells in cancer therapy: identical chemosensitization by metronidazole and misonidazole at moderately elevated temperatures.
    Urano M; Wong KH; Reynolds R; Begley J
    Int J Hyperthermia; 1995; 11(3):379-88. PubMed ID: 7636324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: methotrexate, 5-fluorouracil and adriamycin.
    Tannock IF
    Br J Cancer; 1980 Dec; 42(6):861-70. PubMed ID: 7459220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers.
    Siemann DW
    Br J Cancer; 1982 Feb; 45(2):272-81. PubMed ID: 6460517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: cyclophosphamide and BCNU.
    Tannock IF
    Br J Cancer; 1980 Dec; 42(6):871-80. PubMed ID: 7459221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of misonidazole and hyperthermia on the radiosensitivity of a C3H mouse mammary carcinoma and its surrounding normal tissue.
    Overgaard J
    Br J Cancer; 1980 Jan; 41(1):10-21. PubMed ID: 7362770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of misonidazole or metronidazole pretreatment on the response of the RIF-1 mouse sarcoma to melphalan, cyclophosphamide, chlorambucil and CCNU.
    Twentyman P; Workman P
    Br J Cancer; 1982 Mar; 45(3):447-55. PubMed ID: 7073938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of misonidazole chemosensitization effect by mild local hyperthermia.
    Wong KH; Urano M
    Int J Radiat Oncol Biol Phys; 1992; 23(3):593-8. PubMed ID: 1612960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schedule dependent tumour growth delay, DNA cross-linking and pharmacokinetic parameters in target tissues with cis-diamminedichloroplatinum(II) and etanidazole with or without hyperthermia or radiation.
    Teicher BA; Pfeffer MR; Alvarez Sotomayor E; Herman TS
    Int J Hyperthermia; 1991; 7(5):773-84. PubMed ID: 1834752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of misonidazole chemopotentiation by mild hyperthermia (41 degrees C) in vitro and selective enhancement in vivo.
    Mulcahy RT; Gipp JJ; Tanner MA
    Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Jul; 52(1):57-65. PubMed ID: 3496311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced tumor responses through therapies combining CCNU, MISO and radiation.
    Siemann DW; Hill SA
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1623-6. PubMed ID: 6480451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of hyperthermochemotherapy for human gastric cancer in nude mice by thermosensitization with nitroimidazoles.
    Fujimoto S; Ohta M; Shrestha RD; Kokubun M; Miyoshi T; Mori T; Arimizu N; Okui K
    Br J Cancer; 1988 Jul; 58(1):42-5. PubMed ID: 3166892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is tumour radiosensitization by misonidazole a general phenomenon?
    Denekamp J; Hirst DG; Stewart FA; Terry NH
    Br J Cancer; 1980 Jan; 41(1):1-9. PubMed ID: 7362769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure/activity relationships for the enhancement by electron-affinic drugs of the anti-tumour effect of CCNU.
    Workman P; Twentyman PR
    Br J Cancer; 1982 Aug; 46(2):249-59. PubMed ID: 7150475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo interaction between radiation and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in the absence or presence of misonidazole in mice.
    Siemann DW; Maddison K; Wolf K; Hill SA; Keng PC
    Cancer Res; 1985 Jan; 45(1):198-202. PubMed ID: 3965132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing effect of misonidazole on the response of the RIF-1 tumour to cyclophosphamide.
    Law MP; Hirst DG; Brown JM
    Br J Cancer; 1981 Aug; 44(2):208-18. PubMed ID: 7272187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of misonidazole and WR-2721--II. Modification of tumour radiosensitization.
    Rojas A; Stewart FA; Denekamp J
    Br J Cancer; 1983 Jan; 47(1):65-72. PubMed ID: 6295429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiosensitization of tumors and normal tissues by combined treatment with misonidazole and heat.
    Hofer KG; MacKinnon AR; Schubert AL; Lehr JE; Grimmett EV
    Radiology; 1981 Dec; 141(3):801-9. PubMed ID: 7302238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of environmental conditions (pH, oxygenation, and temperature) on misonidazole cytotoxicity and radiosensitization in vitro and in vivo in FSaIIC fibrosarcoma.
    Holden SA; Teicher BA; Herman TS
    Int J Radiat Oncol Biol Phys; 1991 May; 20(5):1031-8. PubMed ID: 2022503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combinations of CCNU, MISO, and fractionated radiotherapy.
    Siemann DW; Alliet KL
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1379-82. PubMed ID: 3759559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.